Bioceltix S.A. plans to finance part of the costs of the ongoing construction of a pharmaceutical plant through the issue of shares

A publicly traded biotechnology company developing veterinary medicines for companion animals is working with contracted subcontractors to build a large-scale stem cell facility, which will be one of the largest of its kind in the world. The investment is covered by a conditional grant from the Polish Agency for Enterprise Development (PARP), which delays the […]